Clinical Trial Detail

NCT ID NCT01642342
Title Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Southern California
Indications

colorectal adenocarcinoma

hepatocellular carcinoma

Advanced Solid Tumor

pancreatic cancer

gallbladder cancer

head and neck squamous cell carcinoma

malignant mesothelioma

lung non-small cell carcinoma

cholangiocarcinoma

Therapies

sEphB4-HSA

Age Groups: senior adult

No variant requirements are available.